Acute Myeloid Leukemia Market Growth Trajectory, Key Drivers And Trends - PowerPoint PPT Presentation

About This Presentation
Title:

Acute Myeloid Leukemia Market Growth Trajectory, Key Drivers And Trends

Description:

The global acute myeloid leukemia market grew from $1.15 billion in 2022 to $1.29 billion in 2023 at a compound annual growth rate (CAGR) of 12.38%. – PowerPoint PPT presentation

Number of Views:0
Slides: 9
Provided by: ramtbrc
Tags:

less

Transcript and Presenter's Notes

Title: Acute Myeloid Leukemia Market Growth Trajectory, Key Drivers And Trends


1
Acute Myeloid Leukemia Global Market Report 2023
Market Size, Trends and Global Forecast 2023-2032
2
Acute Myeloid Leukemia Market Segments
The Business Research Company segments its Acute
Myeloid Leukemia market report as
Chemotherapy, Radiation therapy, Stem Cell
Transplant, Targeted Therapy
By Treatment Type
By Chemotherapy
Cytarabine, Anthracycline Drugs, Alkylating
Agents, Anti-metabolites, Tyrosine Kinase
Inhibitors, Hormonal Therapy
By End-User

Hospital, Retails Drug Stores, Ambulatory Care
Centers, Clinics
By Industry
3
Market Statistics
The global acute myeloid leukemia market grew
from 1.15 billion in 2022 to 1.29 billion in
2023 at a compound annual growth rate (CAGR) of
12.38. The market size of acute myeloid
leukemia is expected to grow to 2.03 billion in
2027 at a CAGR of 12.03.
Click Here To Get A Sample Report
4
Key Market Drivers And Trends
Drivers
The increase in the older population base and
growing unmet healthcare needs is expected to
propel the growth of the acute myeloid leukemia
market over the coming years
Trends
Growing investments in RD using the
pharmaceutical groups are a key trend gaining
popularity in the acute myeloid leukemia market.
Region
North America was the largest region in the
control valve market. The regions covered in the
global control valve market report are
Asia-Pacific, Western Europe, Eastern Europe,
North America, South America, Middle East and
Africa.
5
Key Market Players
  • Major players in the Acute Myeloid Leukemia
    market are
  • Pfizer Inc.
  • Novartis AG
  • Sanofi-Aventis (Genzyme Corporation)
  • Bristol Myers Squibb
  • Amgen Inc.
  • And more.

6
5 Reasons Why TBRC Is The Solution You Need
  1. Measure the impact of high global inflation on
    market growth
  2. Outperform competitors using forecast data and
    the drivers and trends shaping the market
  3. Get a compreAcute Myeloid Leukemiasive market
    sizing report with a truly global perspective
    covering 60 geographies from The Business
    Research Company, with data from 2017 to 2023 and
    forecasts up to 2032.
  4. Assess the Russia-Ukraine wars impact on
    commodity supply and its direct and indirect
    impact on all the markets
  5. Benchmark performance against key competitors.

7
Americas The Business Research Company, 1295 N
Providence Rd, Acute Myeloid Leukemia, PA 19063,
USA ? 1 3156230293
Get In Touch
Europe The Business Research Company 47 Anchorage
Point, 42 Cuba Street, Canary Wharf, London,
England, E14 8NE ? 44 207 1930 708
How ever you want to grow and expand, The
Business Research Company can help as we provide
research consulting solutions for businesses,
government agencies consultancies, and market
research companies.
Asia The Business Research Company, 1st Floor,
Anshu Colors Building, Road Number 1, Park View
Enclave, Jubilee Hills, Hyderabad (India),
500033 ? 91 8897263534
info_at_tbrc.info
8
Your Growth Insights Partner
Write a Comment
User Comments (0)
About PowerShow.com